Contribution of BLA-mPFC pathway to risky choice and compulsive cocaine seeking
BLA-mPFC 通路对风险选择和强迫性可卡因寻求的贡献
基本信息
- 批准号:10730229
- 负责人:
- 金额:$ 42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAddressAmygdaloid structureAnimal ModelBehaviorBehavioralCathetersCharacteristicsCocaineDecision MakingDiseaseDoseDrug usageEconomicsEducationExtinctionFemaleFoodFundingGeneticGlutamatesGoalsGrantImplantImprisonmentIndividualInfusion proceduresInjectionsInstitutionInterventionKentuckyMeasuresMedialMediatingMethamphetamineModelingN-Methyl-D-Aspartate ReceptorsN-MethylaspartateNeural PathwaysNeurobiologyNeuronsNeurosciences ResearchOverdosePathway interactionsPharmaceutical PreparationsPharmacologyPrefrontal CortexProbabilityPsychological reinforcementPunishmentRattusRecoveryRelapseResearchRewardsRiskRisk BehaviorsRoleShockSubstance Use DisorderTestingTrainingUnited States National Institutes of HealthUniversitiesViral VectorWithdrawaladdictionantagonistbehavioral constructcocaine seekingcocaine self-administrationconditioned place preferencedesigndesigner receptors exclusively activated by designer drugseffective therapyefficacious treatmentenhanced green fluorescent proteinexperienceexperimental studyflexibilityfootgenetic approachmalemeetingsneural circuitneuromechanismnovelpain sensitivityreceptorreinforcerresponsestimulant use disordersubstance misusesubstance useundergraduate studentvector control
项目摘要
Project Summary/Abstract
This is a resubmission of a renewal application for an AREA R15 grant to continue research funded in
DA047610 (“Contribution of NMDA NR2B subunit to risky choice and economic demand for cocaine” now titled
“Contribution of BLA-mPFC pathway to risky choice and compulsive cocaine seeking”). The purpose of the
R15 grant is to stimulate research at primarily educational institutions like Northern Kentucky University (NKU)
that support baccalaureate training but are not recipients of major NIH support. Risky choice is characteristic of
several psychiatric conditions, including substance use disorders (SUDs). Substance misuse can be
considered a risky behavior as individuals can become incarcerated for their drug use or can ultimately die
from overdose. Understanding the neurobiology of risky choice is important for designing effective treatment
interventions for individuals that are at risk for developing SUDs. During our current funding period, we have
shown that the GluN2B subunit of the glutamate N-methyl-D-aspartate (NMDA) receptor mediates risky choice
as assessed in the risky decision task (RDT), and it mediates addiction-like behaviors as measured in cocaine
self-administration and in methamphetamine conditioned place preference. Because the RDT uses foot shock
as punishment, determining if a rat displays increased risky choice or insensitivity to shock is difficult. Thus, the
first goal of the current proposal is to use a novel task to measure risky choice. To this end, rats will be tested
in an equivalent expected value (EEV) task, in which reinforcer magnitude and reinforcement probability will be
adjusted across concurrently available reinforcers such that the expected utility (value) of each alternative is
equivalent. Because the expected value is equivalent across reinforcer alternatives, there is no suboptimal
choice. However, risky choice can be measured by the percentage of responses for the lower probability/larger
reward alternative. To further elucidate the neurocircuitry of risky choice, we will determine if chemogenetic
inhibition of medial prefrontal cortex (mPFC)-projecting basolateral amygdala (BLA) neurons and/or BLA-
projecting mPFC neurons decreases risky choice in the EEV task (Specific Aim 1). Specific Aims 2 and 3 will
utilize the same chemogenetic approach from Specific Aim 1 to determine if the reciprocal connections
between the BLA and the mPFC mediate compulsive cocaine seeking and resurgence of cocaine seeking
(model of relapse-like behavior). Renewed funding will allow us to answer these critical questions and will allow
undergraduate students to continue gaining research experience in behavioral neuroscience research at NKU.
项目摘要/摘要
这是对R15地区资助的继续研究的续期申请的重新提交
DA047610(《NMDANR2B亚基对可卡因风险选择和经济需求的贡献》,现标题为
“BLA-mPFC通路对冒险选择和强迫性寻求可卡因的贡献”)。该计划的目的是
R15拨款是为了刺激北肯塔基大学(NKU)等主要教育机构的研究
他们支持学士学位培训,但不接受NIH的主要支持。高风险的选择是
几种精神疾病,包括物质使用障碍(SUDS)。物质滥用可能是
被认为是一种危险的行为,因为个人可能因吸毒而入狱或最终死亡
因为服药过量。了解风险选择的神经生物学对于设计有效的治疗方法很重要。
对有发生肥皂泡风险的个人进行干预。在我们目前的资助期内,我们有
研究表明,谷氨酸N-甲基-D-天冬氨酸(NMDA)受体的GluN2B亚单位参与风险选择
正如风险决策任务(RDT)中所评估的那样,它介导了可卡因中的成瘾行为
自我给药和在甲基苯丙胺条件性位置偏爱。因为RDT使用脚部电击
作为惩罚,很难确定一只老鼠是否表现出风险更高的选择或对冲击不敏感。因此,
当前提案的第一个目标是使用一项新任务来衡量风险选择。为此,将对老鼠进行测试
在等效期望值(EEV)任务中,增强剂的大小和增援概率将为
在同时可用的增强剂之间进行调整,以使每个替代方案的预期效用(值)为
等价物。由于各增强剂备选方案的期望值相等,因此不存在次最优
选择。然而,风险选择可以通过较低概率/较大概率的响应百分比来衡量
奖励替代方案。为了进一步阐明风险选择的神经回路,我们将确定化学发生是否
抑制内侧前额叶皮质(MPFC)投射杏仁基底外侧核(BLA)神经元和/或BLA-
投射mPFC神经元减少了EEV任务中的风险选择(特定目标1)。具体目标2和3将
利用来自特定目标1的相同的化学发生方法来确定相互联系是否
BLA和mPFC在强迫性寻求可卡因和可卡因再寻求中的作用
(旧病复发的行为模式)。新的资金将使我们能够回答这些关键问题,并将使
本科生继续在NKU获得行为神经科学研究方面的研究经验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Justin Ryan Yates其他文献
Justin Ryan Yates的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Justin Ryan Yates', 18)}}的其他基金
Contribution of NMDA NR2B subunit to risky choice and economic demand for cocaine
NMDA NR2B 亚基对可卡因的风险选择和经济需求的贡献
- 批准号:
10400341 - 财政年份:2019
- 资助金额:
$ 42万 - 项目类别:
Contribution of NMDA NR2B subunit to risky choice and economic demand for cocaine
NMDA NR2B 亚基对可卡因的风险选择和经济需求的贡献
- 批准号:
9812867 - 财政年份:2019
- 资助金额:
$ 42万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 42万 - 项目类别:
Research Grant














{{item.name}}会员




